<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=213807269037206&ev=PageView&noscript=1">
Blog

Compliance In Focus

remote services

LEARN MORE ABOUT REMOTE SERVICES

Keep Your Clinical Trial Moving from a Distance

You want to keep your trial on track, but physical distancing and travel restrictions have made it difficult. Fortunately, IMARC has experience providing remote services.

FILTER BY:

Newest Post

Posted by John Lehmann on Mon, May 23, 2016

Good Clinical Practice: From Review to Applications

In clinical research many rules and regulations exist to govern the way research is conducted and to protect those patients who are participating in research. One of the standard principles directing clinical research is Good Clinical Practice. Good clinical practice is more than any one document; rather, it is a collective compilation of many thoughts, ideas and learning moments spanning the globe over.

Good clinical practice is an attitude of credible excellence in research that provides a standard for clinical study design, implementation, conduct and analysis. Furthermore, good clinical practice is a mind-set that is absolutely essential to the protection of patients’ rights and the assurance of data integrity. Many of these lessons stem from some of the tragedies in the history of clinical research which has formed and shaped much of the frame work today.

Topics: Good Clinical Practice, Whitepaper, IMARC Research

Posted by John Lehmann on Fri, May 15, 2015

Product Accountability in Clinical Trials- Why is it important?

In order for a new medical product to reach patients it must first be proven safe and effective and then be approved for use by the governing regulatory body. Clinical trials are the vehicle to bring these innovative technologies to patients and evaluate them in support of regulatory approval. Unless a product is approved under the appropriate regulations for a specific use, it cannot be commercialized for that indication. In clinical research the products are still investigational, and even in a hospital setting, these products are treated differently.

Topics: Whitepaper, Product Accountability, IMARC Research, Clinical Research

Posted by John Lehmann on Fri, Jun 03, 2016

Auditing versus Monitoring: What’s the Difference?

In the realm of clinical research, two functions often work together to complement each other to create an additive impact on the overall quality and integrity of a clinical trial. The two functions are clinical monitoring and auditing. But how do these work hand-in-hand, and how are they different?

Topics: Whitepaper, IMARC Research, Auditing, Clinical Research, Clinical Monitoring

Posted by John Lehmann on Wed, Mar 04, 2015

Risk Management in Clinical Research

As the regulators continue to raise the bar for quality clinical research investigations, IMARC has released a new whitepaper that discusses the principles of risk management and their application to clinical research.

Topics: Whitepaper, Risk Management, Guidance Document, IMARC Research, FDA

Posted by John Lehmann on Fri, Jun 03, 2016

Auditing versus Monitoring: What’s the Difference?

In the realm of clinical research, two functions often work together to complement each other to create an additive impact on the overall quality and integrity of a clinical trial. The two functions are clinical monitoring and auditing. But how do these work hand-in-hand, and how are they different?

Topics: Whitepaper, IMARC Research, Auditing, Clinical Monitoring

Posted by John Lehmann on Wed, Mar 04, 2015

Misconduct in Clinical Research – Room for Improvement

IMARC Research believes history provides important examples of clinical research misconduct  that have helped establish a foundation for understanding the principles that guide modern clinical research.  If you visit our offices, you will see artwork that is featured in our history of clinical research timeline hanging on our walls that depict critical events in history that have helped shape and improve modern clinical research for the well-being of human subjects.

Topics: Whitepaper, Misconduct in Clinical Research, IMARC Research

Posted by Brandy Chittester on Wed, Mar 04, 2015

What is the FAIR Shake™?

Topics: FAIR Shake, Whitepaper, IMARC Research

Posted by John Lehmann on Wed, Mar 04, 2015

Laying the Regulatory Groundwork for a Successful Physician-Sponsored IDE Study

When a Sponsor-Investigator conducts a device study, it may be referred to as a Physician-Sponsored IDE (PS-IDE). Chaos can sometimes ensue when one begins down the path of a PS-IDE. This whitepaper will attempt to make sense of that chaos by providing a brief overview of initiating a PS-IDE, the responsibilities of the investigator, the additional sponsor responsibilities assumed by the Sponsor-Investigator, and a thoughtful discussion on the records and reports of the Sponsor-Investigator.  Relevant FDA warning letter findings issued to Sponsor-Investigators and some suggestions to ensure a well-controlled clinical study are reviewed.

Topics: Whitepaper, IMARC Research, FDA, Physician-Sponsored IDE Study

Posted by John Lehmann on Wed, Mar 04, 2015

Conducting a Well-Controlled Clinical Study When Clinical Data is Required

There continues to be much discussion over the FDA’s 510(k) program, which has led to controversy and confusion over the direction of the program.  In fact, we have posted many blogs devoted to this topic, so we thought it was time to create a whitepaper focusing on the topic.

Topics: Whitepaper, 510(k) Program, IMARC Research, FDA

Posted by Jacqui Lingler on Wed, Mar 04, 2015

Monitoring as a Mindset

While procedures, checklists, guidance documents, report templates and all sorts of other things combine to form the infrastructure for monitoring, what is possibly even more important is the shared mindset.  The acceptance by all that regardless of the title, there is a shared responsibility in calling out issues, in looking purposefully at this document, in questioning that blank. 

Topics: Whitepaper, IMARC Research, Clinical Monitoring

Posted by Brandy Smith on Wed, Mar 04, 2015

How to Improve Individual Site Compliance

In order to run a well-controlled compliant study at the site level, one must ensure that the study team has been trained, and is knowledgeable on the rules and regulations. Although it is the Investigator who is responsible for the conduct of the study, there is a larger team at work to complete all the required activities. The research coordinator carries out many of the day-to-day activities and touches nearly every study milestone.

Topics: Site Compliance, Whitepaper, Improve Site Compliance, IMARC Research